PACIRA BIOSCIENCES INC. - COMMON STOCK

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

26 Sep 2023 08:45:02 By NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

12 Sep 2023 09:13:18 By NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

11 Sep 2023 08:45:21 By NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

08 Sep 2023 08:49:49 By NetDania Notify

Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference

06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

02 Aug 2023 08:45:11 By NetDania Notify

Pacira BioSciences Reports Second Quarter 2023 Financial Results

02 Aug 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023

26 Jul 2023 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference

31 May 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference

09 May 2023 07:00:02 By Nasdaq GlobeNewswire

Pacira BioSciences Reports First Quarter 2023 Financial Results

03 May 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023

26 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner

20 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer

19 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources

03 Apr 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira Announces FDA Acceptance of sNDA for Exparel Nerve Blocks to Produce Regional Analgesia in Lower Extremity Procedures

29 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Third Circuit Court Upholds Decision to Dismiss Pacira BioSciences, Inc. Lawsuit

27 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors

22 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2023 Barclays Global Healthcare Conference

08 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2022 Financial Results

28 Feb 2023 07:00:03 By Nasdaq GlobeNewswire